Summit Therapeutics PLC (SMMT)
Healthcare
Biotechnology
13.00 $
-3.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Summit Therapeutics PLC (SMMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -240 million GBP. Tick rows to compare them in a chart.
All figures in millions of GBP.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17 | -24 | 15 | -21 | -35 | -27 | -35 | -54 | -34 | -61 | -114 | -240 | |
| 0.0 | 0.1 | 0.1 | 0.6 | 2.0 | 1.4 | 1.5 | 1.8 | 1.0 | 0.2 | 0.1 | 0.1 | |
| 1.4 | 1.7 | 1.7 | 2.3 | 6.3 | 0.5 | 1.3 | 9.5 | 9.7 | 11 | 41 | 544 | |
| 2.2 | 2.2 | 1.6 | 0.3 | 3.6 | 4.5 | 4.6 | 14 | 26 | – | – | – | |
| -0.7 | 1.1 | 40 | 6.9 | -55 | 1.0 | 0.5 | 0.0 | 8.0 | -0.4 | 12 | 23 | |
| 0.1 | 0.1 | 0.1 | 0.7 | 0.2 | 0.3 | 0.3 | 0.2 | 0.5 | 0.1 | 0.1 | 0.5 | |
| 0.0 | -0.1 | -0.1 | -7.4 | -0.3 | -0.1 | -0.3 | -0.2 | -0.5 | -465 | -164 | -129 | |
| – | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 31 | 1,000,000,000,000 | 1,000,000,000,000 | 1,000,000,000,000 | 0.0 | – | – | – | – | – | – | – | |
| -0.3 | 0.0 | 0.0 | -0.1 | -0.3 | -0.4 | 520 | 520 | 520 | -25 | -100 | 0.0 | |
| 30 | 32 | 0.5 | 19 | 45 | 33 | 37 | 58 | 506 | 68 | 305 | 458 | |
| 14 | 7.2 | 15 | -11 | 6.8 | 6.8 | 1.9 | 4.0 | 470 | -457 | 27 | 89 | |
| -17 | -25 | 15 | -21 | -35 | -16 | -36 | -54 | -34 | -61 | -114 | -240 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.